JFG
MRNS

Jefferies Financial Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Jefferies Financial Group’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50,000
Closed -$544K – 2133
2023
Q4 		$544K Hold
50,000
– – ﹤0.01% 1185
2023
Q3 		$403K Buy
+50,000
New +$416K ﹤0.01% 1141

Other funds holding MRNS

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Jefferies Financial Group's MRNS Position: Q3 2024 in Review

Jefferies Financial Group sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2024, closing a stake of 41,686 shares — an estimated $48.8K sold.

Jefferies Financial Group first reported a position in MRNS in Q4 2022 and held it in 7 quarters. The position peaked at $3.48M in Q1 2023. 75 funds tracked by Wall St. Rank hold MRNS as of Q3 2024.

  • Jefferies Financial Group reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 41,686 Marinus Pharmaceuticals, Inc shares in Q3 2024, an estimated $48.8K.
  • Jefferies Financial Group first reported a position in Marinus Pharmaceuticals, Inc in Q4 2022 and held it in 7 quarters.
  • Jefferies Financial Group's Marinus Pharmaceuticals, Inc position peaked at $3.48M in Q1 2023.
  • 75 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2024.

Based on Jefferies Financial Group's 13F filing for Q3 2024, filed 14 Nov 2024.